Rio P. Juni

1.2k total citations
23 papers, 860 citations indexed

About

Rio P. Juni is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Rio P. Juni has authored 23 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Rio P. Juni's work include Circular RNAs in diseases (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Rio P. Juni is often cited by papers focused on Circular RNAs in diseases (7 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Rio P. Juni collaborates with scholars based in Netherlands, Germany and Portugal. Rio P. Juni's co-authors include An L. Moens, Pieter Koolwijk, Victor W.M. van Hinsbergh, Diederik W.D. Kuster, Jolanda van der Velden, Henricus J. Duckers, Renu Virmani, Reinier A. Boon, Paul M. Vanhoutte and Max Goebel and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and FEBS Letters.

In The Last Decade

Rio P. Juni

22 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rio P. Juni Netherlands 12 308 291 274 205 152 23 860
Giovanna Castoldi Italy 18 416 1.4× 311 1.1× 205 0.7× 133 0.6× 80 0.5× 38 931
Hiroe Toba Japan 22 486 1.6× 490 1.7× 226 0.8× 261 1.3× 159 1.0× 52 1.3k
Ornella Carbonara Italy 15 324 1.1× 385 1.3× 383 1.4× 189 0.9× 92 0.6× 22 998
Yunhong Lu China 8 393 1.3× 254 0.9× 395 1.4× 252 1.2× 72 0.5× 12 917
Deng-feng Geng China 17 306 1.0× 245 0.8× 103 0.4× 146 0.7× 120 0.8× 40 819
Dingliang Zhu China 21 361 1.2× 392 1.3× 247 0.9× 371 1.8× 182 1.2× 52 1.2k
Tieqiang Zhao United States 20 455 1.5× 477 1.6× 118 0.4× 203 1.0× 104 0.7× 35 1.1k
Kazuya Miyashita Japan 19 266 0.9× 542 1.9× 562 2.1× 138 0.7× 94 0.6× 70 1.2k
Isamu Fukamachi Japan 16 167 0.5× 270 0.9× 377 1.4× 282 1.4× 127 0.8× 33 769
Mathias Burgmaier Germany 20 265 0.9× 354 1.2× 283 1.0× 420 2.0× 92 0.6× 55 1.0k

Countries citing papers authored by Rio P. Juni

Since Specialization
Citations

This map shows the geographic impact of Rio P. Juni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rio P. Juni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rio P. Juni more than expected).

Fields of papers citing papers by Rio P. Juni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rio P. Juni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rio P. Juni. The network helps show where Rio P. Juni may publish in the future.

Co-authorship network of co-authors of Rio P. Juni

This figure shows the co-authorship network connecting the top 25 collaborators of Rio P. Juni. A scholar is included among the top collaborators of Rio P. Juni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rio P. Juni. Rio P. Juni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juni, Rio P., et al.. (2025). Long Non-coding RNA Based Therapy for Cardiovascular Disease. Journal of Cardiovascular Translational Research. 18(6). 1511–1524.
2.
Boon, Reinier A., et al.. (2024). Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine. 10. 1300375–1300375. 9 indexed citations
3.
Lozano‐Vidal, Noelia, Laura Stanicek, Diewertje I. Bink, et al.. (2024). Aging-regulated PNUTS maintains endothelial barrier function via SEMA3B suppression. Communications Biology. 7(1). 541–541. 1 indexed citations
4.
Juni, Rio P., Ricardo C. de Abreu, Aliaksei Vasilevich, et al.. (2023). MicroRNA-216a is essential for cardiac angiogenesis. Molecular Therapy. 31(6). 1807–1828. 6 indexed citations
5.
Tammaro, Alessandra, Kimberly J. Reid, Rio P. Juni, et al.. (2023). HDAC1/2 inhibitor therapy improves multiple organ systems in aged mice. iScience. 27(1). 108681–108681. 9 indexed citations
6.
Boon, Reinier A., et al.. (2022). The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases. Clinical Science. 136(15). 1157–1178. 40 indexed citations
7.
Juni, Rio P., et al.. (2022). Long noncoding RNAs in cardiometabolic disorders. FEBS Letters. 596(11). 1367–1387. 11 indexed citations
8.
Juni, Rio P., Diederik W.D. Kuster, Jolanda van der Velden, et al.. (2020). Empagliflozin Restores CKD-Induced Impairment of Endothelial Regulation of Cardiomyocyte Relaxation and Contraction. Journal of the American Society of Nephrology. 31(10S). 246–246. 1 indexed citations
9.
Juni, Rio P., Diederik W.D. Kuster, Jolanda van der Velden, et al.. (2020). Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction. Kidney International. 99(5). 1088–1101. 55 indexed citations
10.
Juni, Rio P., Diederik W.D. Kuster, Max Goebel, et al.. (2019). Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin. JACC Basic to Translational Science. 4(5). 575–591. 152 indexed citations
11.
Uthman, Laween, Rio P. Juni, Raphaela P. Kerindongo, et al.. (2019). Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells. Cellular Physiology and Biochemistry. 53(5). 865–886. 168 indexed citations
12.
Juni, Rio P., Julie Halkein, Hamid el Azzouzi, et al.. (2019). Abstract 896: Cardiomyocyte-derived Mir-200c-3p In Exosomes Affects Endothelial Angiogenic Capacity And Impairs Cardiac Function. Circulation Research. 125(Suppl_1). 3 indexed citations
13.
Juni, Rio P., Julie Halkein, Hamid el Azzouzi, et al.. (2018). Cardiomyocyte-derived exosomes mediate pathological cardiac microvascular remodeling. Journal of Molecular and Cellular Cardiology. 120. 45–45. 3 indexed citations
14.
Juni, Rio P., et al.. (2018). Comparison of different chemically modified inhibitors of miR-199b in vivo. Biochemical Pharmacology. 159. 106–115. 19 indexed citations
15.
Juni, Rio P., et al.. (2018). FGF23 impairs peripheral microvascular function in renal failure. American Journal of Physiology-Heart and Circulatory Physiology. 315(5). H1414–H1424. 28 indexed citations
16.
Juni, Rio P., et al.. (2017). miR-199b-5p is a regulator of left ventricular remodeling following myocardial infarction. Non-coding RNA Research. 2(1). 18–26. 30 indexed citations
17.
Juni, Rio P., Ricardo C. de Abreu, & Paula A. da Costa Martins. (2017). Regulation of microvascularization in heart failure - an endothelial cell, non-coding RNAs and exosome liaison. Non-coding RNA Research. 2(1). 45–55. 13 indexed citations
18.
Deel, Elza D. van, Yanti Octavia, Martine de Boer, et al.. (2015). Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload. Journal of Molecular and Cellular Cardiology. 88. 145–154. 11 indexed citations
19.
Juni, Rio P., Henricus J. Duckers, Paul M. Vanhoutte, Renu Virmani, & An L. Moens. (2013). Oxidative Stress and Pathological Changes After Coronary Artery Interventions. Journal of the American College of Cardiology. 61(14). 1471–1481. 97 indexed citations
20.
Juni, Rio P., et al.. (2011). Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities. American Journal of Physiology-Endocrinology and Metabolism. 302(5). E481–E495. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026